Attending the Developing Country Vaccine Manufacturers Network (DCVMN) Annual Meeting in São Paulo, Brazil? Stop by Sunflower's booth 4, say hello to Laura Crowell and Alexandra Bonnyman, and learn more about our next-generation protein manufacturing solutions, designed for anyone to use, anywhere. #DCVMNAnnualMeeting #perfusionfermentation #continuousmanufacturing #democratizebioprocess
Sunflower Therapeutics
Biotechnology
Medford, MA 1,851 followers
Proteins for Everyone, Made by Anyone.™
About us
Sunflower Therapeutics is a unique biotechnology start-up focused on dramatically reducing the time and cost to develop and manufacture biologics for patients around the world. With a genetically-optimized host, data-driven process development, and a novel, ‘right-sized’ manufacturing unit, the experienced Sunflower team is creating an efficient, patient-centered, end-to-end drug production platform that we plan to deploy worldwide.
- Website
-
https://www.sunflowertx.com
External link for Sunflower Therapeutics
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Medford, MA
- Type
- Privately Held
- Founded
- 2018
- Specialties
- Biotechnology, Biologics, Global Health, and Perfusion Fermentation
Locations
-
Primary
Medford, MA 02155, US
Employees at Sunflower Therapeutics
Updates
-
In a new article in BioPharm International, Kerry Love 🌻, Stacy Martin, and Laura Crowell discuss space-time yield as a critical metric for comparison of upstream biomanufacturing processes and how it can be useful in reducing commercial production costs. The article demonstrates how to calculate space-time yield using Pichia pastoris (and Chinese hamster ovary (CHO) cells) as model organisms, highlighting the unique differences between fed-batch and perfusion fermentation processes that result in divergent space-time yields. “High space-time yields ultimately result in more protein for less space and time, and therefore lower process and facility investments and production operating costs,” they discussed. “Space-time yield should be considered as a critical metric when assessing process designs to achieve translational, clinical, and commercial manufacturing goals for a given protein product.” Read the full article here: https://lnkd.in/g63u5qQN #continuousfermentation #perfusionbioreactor #biotech #perfusionfermentation
-
Our Founder, CEO, and President, Kerry Love, recently joined Meg Sinclair on Qualio’s From Lab to Launch podcast to explore the future of biologics and Sunflower’s mission to enhance global vaccine accessibility through cutting-edge protein manufacturing technologies. Kerry highlighted how our modular, automated, and fully integrated platform simplifies the complexities of bioproduction, empowering innovators to develop essential biologic medicines that enhance scalability and improve facility planning and resource management. Tune in to the full episode to discover how we’re advancing biologics for a healthier future: https://lnkd.in/ep7ZqZfJ #Biologics #VaccineAccessibility #Innovation
The future of protein manufacturing with Kerry Love, co-founder of Sunflower Therapeutics
podcasts.apple.com
-
"When we think about vaccine and drug development on a global scale, it’s important to note that it’s not a one-size-fits-all approach. Genetic and regional differences mean that vaccines and drugs must be tailored to effectively meet the unique requirements of various populations," said our Founder, CEO & President, Kerry Love. More in MedCity News about why accessible, worldwide biomanufacturing solutions are paramount, here: https://lnkd.in/d-2jmkRq
Why Accessible, Worldwide Biomanufacturing Solutions are Paramount - MedCity News
https://medcitynews.com
-
Planning to attend the ISPE Boston Area Chapter’s Product Show on Wednesday, October 2nd at Gillette Stadium? Stop by our booth (W115) to learn more about our next gen #proteinmanufacturing solutions that #empower innovators to keep pace with the rapidly expanding market for new innovative medicines, food products, and other bio-related products. #ISPEproductshow #continuousmanufacturing #democratizebioprocess
-
Do you know about our GMP-compliant bioprocessing software suite? Together, HelianthOS™, Nursery™, and Harvest™ provide a cohesive ecosystem that enables efficient and intuitive operations throughout an entire campaign. Watch the video below to learn more about how these tools make #proteinproduction accessible to everyone. For additional information, please visit https://lnkd.in/edg2T8ah or contact us to learn more! #accessibility #automation #bioprocessing #continuousmanufacturing
-
Attending BioProcess International 2024 next week? Our very own Kerry Love 🌻 Love will be speaking at the BIG (BioInnovation Group) Executive Summit on September 25. She’ll be discussing the #democratization of protein supply through #accessible biomanufacturing. #democratizebioprocess #proteinmanufacturing #innovation
Excited to share that I’ll be speaking at BioProcess International next week on September 25 at the BIG (BioInnovation Group) Executive Summit. In this session, I’ll be discussing: 🌎 The Growing Demand for Innovative Biomanufacturing Solutions: There is an increasing global need for efficient and flexible biomanufacturing solutions to support the development of various protein-based products, including biologics, vaccines, and diagnostics, well before market demand is established. 🥼 The Impact of Continuous Manufacturing Technologies: Continuous manufacturing technologies, especially those that integrate separate unit operations through automation, are enhancing the accessibility of bioprocessing for a wide range of biotechnology products and improving efficiency. 🌻 Sunflower Therapeutics’ Innovation: Sunflower Therapeutics has developed a pioneering approach with fully-automated, small-footprint manufacturing solutions that are both resource-efficient and accessible, aimed at improving local biomanufacturing capabilities and promoting self-sufficiency and regional bio economies. #BPIUS2024 #democratizebioprocess #biotech
-
Today, we celebrate the #5yearanniversary since our operationalization here at Sunflower Therapeutics.🌻 As we look back on this incredible journey, one thing is certain: we would not be where we are today without our remarkable staff. To commemorate our #5yearanniversary since operationalization, our Co-Founder, CEO and President Kerry Love wrote a letter summarizing our journey over the years, highlighting some of our key milestones as a company, and celebrating our champions throughout the years. #companyanniversary #democratizebioprocess #milestones
Celebrating Five Years of Sunflower Therapeutics: A Journey of Growth, Challenges, and Gratitude
Sunflower Therapeutics on LinkedIn
-
Manufacturing proteins has long been a complex and costly challenge, but innovation is on the horizon! We’re thrilled to see our work spotlighted in michael dumiak’s recent IAVI report. The report highlights the remarkable progress being made in biotech, and we’re excited to be part of this transformative journey. We’re particularly proud of our Daisy Petal bioreactor, which represents a step forward in continuous, small-batch production. This innovation, along with other breakthroughs mentioned, demonstrates the collective effort to enhance accessibility and affordability in healthcare. Thank you, Michael, for your insightful coverage and for capturing the spirit of innovation and teamwork in this field. Together, we’re making strides toward a healthier, more equitable world. Explore more about these advancements and the amazing work being done across the industry: https://lnkd.in/eYfPtsZJ. #BiotechInnovation #ProteinManufacturing #DaisyPetal #GlobalHealth #BiotechBreakthroughs #HealthEquity
Facing stubborn manufacturing challenges
https://www.iavi.org
-
Now that our interns have both wrapped up their work for the summer, we wanted to extend our sincere appreciation to our summer intern Molly Lynch for her hard work and dedication. During her time at Sunflower Therapeutics, Molly focused on media and fermentation development, gaining hands-on experience with different scales and modes of fermentation, from plate and flask to bioreactor, and exploring batch vs. continuous processes. Her contributions and enthusiasm have been greatly valued by our team. Thank you, Molly, for your commitment and for being a part of our innovative team! We have no doubt you’ll achieve great things! #internship #research #teamwork #sciencecareers